{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T04:51:05Z","timestamp":1790139065277,"version":"4.0.1"},"reference-count":26,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>Antiphospholipid syndrome (APS) is an autoimmune disease that is associated with recurrent pregnancy loss. It is still controversial whether the presence of antiphospholipid antibodies (aPL) in the serum of patients with in vitro fertilization-embryo transfer (IVF-ET) has a negative effect on the outcomes. In view of the discrepancies, a meta-analysis of the published data was performed to explore the relationship of aPL and IVF-ET outcomes.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>We searched for all published articles indexed in PubMed, Web of Science, and Cochrane Library, which were retrieved up to April, 2021. A total of 921 studies were yielded, of which 6 finally met the inclusion criteria. We carried out the meta-analysis by pooling results of these studies with Review Manager 5.3 software. The effect index was measured with 95% confidence intervals (CIs) of the relative risks (RRs).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>Six eligible studies were included in this meta-analysis, involving 3214 patients. Our results showed that positive aPL was not associated with decreased clinical pregnancy rate (RR 0.97; 95% CI 0.91-1.04). There was no correlation between positive aPL and increased miscarriage risk (RR 1.22; 95% CI 0.94-1.58). Only 5 of the 6 studies referred to live birth rate, but still no association was found between them (RR 0.95; 95% CI 0.81-1.11).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>The results showed that the presence of positive aPL neither decreased clinical pregnancy rate and live birth rate, nor increased miscarriage rate in women undergoing IVF, which is differed from the opinion of clinical practice. More prospective studies with high quality and larger sample size are needed to evaluate the relationship between positive aPL and outcomes of IVF-ET.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000029146","type":"journal-article","created":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T16:02:49Z","timestamp":1648742569000},"page":"e29146","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":12,"title":["Serum antiphospholipid antibody status may not be associated with the pregnancy outcomes of patients undergoing in vitro fertilization"],"prefix":"10.1097","volume":"101","author":[{"given":"Xiao-Fang","family":"Tan","sequence":"first","affiliation":[{"name":"Department of Reproductive Medicine Centre, Affiliated Maternity & Child Health Care Hospital of Nantong University, Nantong, Jiangsu province, China,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Reproductive Medicine Centre, Affiliated Maternity & Child Health Care Hospital of Nantong University, Nantong, Jiangsu province, China,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting-Ting","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Reproductive Medicine Centre, Affiliated Maternity & Child Health Care Hospital of Nantong University, Nantong, Jiangsu province, China,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan-Ting","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Reproductive Medicine Centre, Affiliated Maternity & Child Health Care Hospital of Nantong University, Nantong, Jiangsu province, China,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Wei","family":"Ma","sequence":"additional","affiliation":[{"name":"Department of Reproductive Medicine Centre, Affiliated Maternity & Child Health Care Hospital of Nantong University, Nantong, Jiangsu province, China,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-Yi","family":"Ding","sequence":"additional","affiliation":[{"name":"Department of Reproductive Medicine Centre, Affiliated Maternity & Child Health Care Hospital of Nantong University, Nantong, Jiangsu province, China,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5996-2376","authenticated-orcid":false,"given":"Hong-Li","family":"Dong","sequence":"additional","affiliation":[{"name":"Scientific Education Section and Department of Child Healthcare, Affiliated Maternity & Child Health Care Hospital of Nantong University, Nantong, Jiangsu province, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2022,3,25]]},"reference":[{"key":"R1-20250504","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1097\/01.JAA.0000526771.67820.59","article-title":"Antiphospholipid antibody syndrome: the difficulties of diagnosis.","volume":"30","author":"Whitaker","year":"2017","journal-title":"JAAP"},{"key":"R2-20250504","first-page":"2","article-title":"Pregnancy and antiphospholipid syndrome.","volume":"178","author":"Schreiber","year":"2016","journal-title":"Uqeskr Laeqer"},{"key":"R3-20250504","first-page":"42","article-title":"ESHRE guideline: recurrent pregnancy loss.","volume":"2018","author":"Atik","year":"2018","journal-title":"Hum Reprod Open"},{"key":"R4-20250504","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.1016\/j.fertnstert.2009.08.062","article-title":"Prevalence of antiphospholipid antibodies among women experiencing unexplained infertility and recurrent implantation failure.","volume":"93","author":"Sauer","year":"2010","journal-title":"Fertil Steril"},{"key":"R5-20250504","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/S0015-0282(99)00498-7","article-title":"Antiphospholipid antibodies and in vitro fertilization success: a metaanalysis.","volume":"73","author":"Hornstein","year":"2000","journal-title":"Fertil Steril"},{"key":"R6-20250504","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/S0015-0282(00)01525-9","article-title":"A rational basis for antiphospholipid antibody testing and selective immunotherapy in assisted reproduction: a rebuttal to the American Society for Reproductive Medicine Practice Committee opinion.","volume":"74","year":"2000","journal-title":"Fertil Steril"},{"key":"R7-20250504","doi-asserted-by":"crossref","first-page":"820","DOI":"10.7326\/0003-4819-127-9-199711010-00008","article-title":"Quantitative synthesis in systematic reviews.","volume":"127","author":"Lau","year":"1997","journal-title":"Ann Intern Med"},{"key":"R8-20250504","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses.","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"R9-20250504","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1093\/oxfordjournals.humrep.a019352","article-title":"Antiphospholipid antibodies in women having in-vitro fertilization.","volume":"11","author":"Birdsall","year":"1996","journal-title":"Hum Reprod"},{"key":"R10-20250504","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1016\/S0015-0282(97)81443-4","article-title":"Antiphospholipid antibodies and pregnancy rates and outcome in in vitro fertilization patients.","volume":"67","author":"Denis","year":"1997","journal-title":"Fertil Steril"},{"key":"R11-20250504","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/S0015-0282(99)00585-3","article-title":"Pregnancy outcome is not affected by antiphospholipid antibody status in women referred for in vitro fertilization.","volume":"73","author":"Chilcott","year":"2000","journal-title":"Fertil Steril"},{"key":"R12-20250504","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1196\/annals.1422.048","article-title":"Antigenic profile, prevalence, and clinical significance of antiphospholipid antibodies in women referred for in vitro fertilization.","volume":"1108","author":"Sanmarco","year":"2007","journal-title":"Ann N Y Acad Sci"},{"key":"R13-20250504","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.jri.2017.08.002","article-title":"Association of serum autoantibodies with pregnancy outcome of patients undergoing first IVF\/ICSI treatment: a prospective cohort study.","volume":"122","author":"Chen","year":"2017","journal-title":"J Reprod Immunol"},{"key":"R14-20250504","doi-asserted-by":"crossref","first-page":"359","DOI":"10.5468\/ogs.2018.61.3.359","article-title":"Impact of presence of antiphospholipid antibodies on in vitro fertilization outcome.","volume":"61","author":"Hong","year":"2018","journal-title":"Obstet Gynecol Sci"},{"key":"R15-20250504","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1111\/j.1600-0897.2011.01058.x","article-title":"Impact of anticardiolipin antibody on the outcome of in vitro fertilization and embryo transfer.","volume":"66","author":"Zhong","year":"2011","journal-title":"Am J Reprod Immunol"},{"key":"R16-20250504","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1016\/S0140-6736(10)60709-X","article-title":"Antiphospholipid syndrome.","volume":"376","author":"Ruiz-Irastorza","year":"2010","journal-title":"Lancet"},{"key":"R17-20250504","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1538-7836.2006.01753.x","article-title":"International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS).","volume":"4","author":"Miyakis","year":"2006","journal-title":"J Thromb Haemost"},{"key":"R18-20250504","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1111\/aogs.12038","article-title":"Anti-\u03b22 glycoprotein I antibodies and pregnancy outcome in antiphospholipid syndrome.","volume":"92","author":"Liu","year":"2013","journal-title":"Acta Obstet Gynecol Scand"},{"key":"R19-20250504","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.jri.2017.09.007","article-title":"Antiphospholipid syndrome and recurrent miscarriage: a systematic review and metaanalysis.","volume":"123","author":"Santos","year":"2017","journal-title":"J Reprod Immunol"},{"key":"R20-20250504","doi-asserted-by":"crossref","first-page":"314704","DOI":"10.1155\/2014\/314704","article-title":"Antiphospholipid antibodies in women undergoing in vitro fertilization treatment: clinical value of IgA Anti- \u03b22glycoprotein I antibodies determination.","volume":"2014","author":"Paulmyer-Lacroix","year":"2014","journal-title":"Biomed Res Int"},{"key":"R21-20250504","doi-asserted-by":"crossref","first-page":"S184","DOI":"10.1016\/j.fertnstert.2004.05.042","article-title":"Anti-phospholipid antibodies do not affect IVF success.","volume":"82","year":"2004","journal-title":"Fertil Steril"},{"key":"R22-20250504","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.revmed.2014.08.004","article-title":"In vitro fertilization and systemic lupus erythematosus or antiphospholipid syndrome: an update.","volume":"36","author":"Orquevaux","year":"2015","journal-title":"Rev Med Interne"},{"key":"R23-20250504","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1160\/TH14-05-0416","article-title":"Diagnosis and management of non-criteria obstetric antiphospholipid syndrome.","volume":"113","author":"Arachchillage","year":"2015","journal-title":"Thromb Haemost"},{"key":"R24-20250504","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.rbmo.2013.05.018","article-title":"Implantation in assisted reproduction: a look at endometrial receptivity.","volume":"27","author":"Fatemi","year":"2013","journal-title":"Reprod Biomed Online"},{"key":"R25-20250504","first-page":"1","article-title":"The role of lymphocytic cells in infertility and reproductive failures in women with antiphospholipid antibodies.","volume":"25","author":"Krivonos","year":"2020","journal-title":"J Matern Fetal Neonatal Med"},{"key":"R26-20250504","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1093\/humupd\/dmt032","article-title":"Adjunct low-molecularweight heparin to improve live birth rate after recurrent implantation failure: a systematic review and meta-analysis.","volume":"19","author":"Potdar","year":"2013","journal-title":"Hum Reprod Update"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000029146","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T03:07:40Z","timestamp":1746328060000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000029146"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,25]]},"references-count":26,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000029146","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,25]]},"assertion":[{"value":"2021-08-29 2022-02-22","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-03-03","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}